MarkRobbinsMD

Cardiology • Nashville, TN

Adult Congenital Heart Disease, Interventional Cardiology

Assistant Professor, Medicine, Vanderbilt University School of Medicine

Join to view full profile

Dr. Robbins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Robbins' full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3000

Education & Training

Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2000 - 2001
Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1997 - 1999
University of Mississippi Medical CenterChief Residency, Internal Medicine, 1996 - 1997
Vanderbilt University Medical CenterResidency, Internal Medicine, 1993 - 1996
University of Mississippi School of MedicineClass of 1993

Certifications & Licensure

TN State Medical License 1994 - 2025
KY State Medical License 2001 - 2015
OH State Medical License 2000 - 2001
National Board of Physicians and Surgeons Cardiovascular Disease
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Interventional Cardiology
American Board of Vascular Medicine

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
Active, not recruiting
Not Applicable

Publications & Presentations

PubMed

6 citations
Percutaneous management of RetroFlex 3 balloon rupture and separation of the Edwards Sapien delivery system.
Kelly D. Green, Alain Waked, Usman Majeed, Marat Fudim, Mark A. Robbins
Texas Heart Institute Journal. 2014-12-01
152 citations
Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Graf...
Marco Roffi, Debabrata Mukherjee, Derek P. Chew, Deepak L. Bhatt, Leslie Cho
Circulation. 2002-12-10
1010 citations
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.
Matthew J. Price, Peter B. Berger, Paul S. Teirstein, Jean-François Tanguay, Dominick J. Angiolillo
JAMA. 2011-03-16

Professional Memberships

American College of Cardiology - ACC
Member